|
Molecular properties generated using the CDK |
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
2-(3-pentylphenyl)acetic acid |
International Nonproprietary Names ![]() |
|
INN number | INN |
10332 | setogepram |
Synonyms ![]() |
3-pentylbenzeneacetic acid | PBI-4050 | PBI4050 |
Comments |
PBI-4050 is an orally active, synthetic analogue of a medium-chain fatty acid that displays agonist and antagonist ligand affinity toward GPR40 and GPR84, respectively [1]. it is a potentially novel first-in-class compound with significant antifibrotic and antiinflammatory activities that is being developed by Prometic Life Sciences. |
Database Links ![]() |
|
CAS Registry No. | 1002101-19-0 (source: WHO INN record) |
GtoPdb PubChem SID | 375973231 |
PubChem CID | 24749700 |
Search Google for chemical match using the InChIKey | PEGQOIGYZLJMIB-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | PEGQOIGYZLJMIB |
Search PubMed clinical trials | setogepram |
Search PubMed titles | setogepram |
Search PubMed titles/abstracts | setogepram |
Search UniChem for chemical match using the InChIKey | PEGQOIGYZLJMIB-UHFFFAOYSA-N |
Search UniChem for chemicals with the same backbone | PEGQOIGYZLJMIB |